1. Home
  2. APRE vs DATS Comparison

APRE vs DATS Comparison

Compare APRE & DATS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • APRE
  • DATS
  • Stock Information
  • Founded
  • APRE 2006
  • DATS 2014
  • Country
  • APRE United States
  • DATS United States
  • Employees
  • APRE N/A
  • DATS N/A
  • Industry
  • APRE Biotechnology: Biological Products (No Diagnostic Substances)
  • DATS Computer Software: Prepackaged Software
  • Sector
  • APRE Health Care
  • DATS Technology
  • Exchange
  • APRE Nasdaq
  • DATS Nasdaq
  • Market Cap
  • APRE 13.5M
  • DATS 10.9M
  • IPO Year
  • APRE 2019
  • DATS 2021
  • Fundamental
  • Price
  • APRE $1.50
  • DATS $2.50
  • Analyst Decision
  • APRE Strong Buy
  • DATS
  • Analyst Count
  • APRE 2
  • DATS 0
  • Target Price
  • APRE $15.50
  • DATS N/A
  • AVG Volume (30 Days)
  • APRE 29.2K
  • DATS 924.7K
  • Earning Date
  • APRE 05-13-2025
  • DATS 05-13-2025
  • Dividend Yield
  • APRE N/A
  • DATS N/A
  • EPS Growth
  • APRE N/A
  • DATS N/A
  • EPS
  • APRE N/A
  • DATS N/A
  • Revenue
  • APRE $1,502,581.00
  • DATS $436.00
  • Revenue This Year
  • APRE N/A
  • DATS N/A
  • Revenue Next Year
  • APRE N/A
  • DATS N/A
  • P/E Ratio
  • APRE N/A
  • DATS N/A
  • Revenue Growth
  • APRE 157.63
  • DATS N/A
  • 52 Week Low
  • APRE $1.41
  • DATS $1.01
  • 52 Week High
  • APRE $5.90
  • DATS $9.34
  • Technical
  • Relative Strength Index (RSI)
  • APRE 27.07
  • DATS 47.23
  • Support Level
  • APRE $1.41
  • DATS $2.12
  • Resistance Level
  • APRE $1.59
  • DATS $2.44
  • Average True Range (ATR)
  • APRE 0.11
  • DATS 0.26
  • MACD
  • APRE 0.02
  • DATS -0.05
  • Stochastic Oscillator
  • APRE 18.60
  • DATS 29.81

About APRE Aprea Therapeutics Inc. Common stock

Aprea Therapeutics Inc is a clinical-stage biopharmaceutical company. The group is focused on precision oncology through synthetic lethality. Its pipeline product is ATRN-119, a clinical-stage small molecule ATR inhibitor in development for solid tumor indications. APR-1051, an oral, small-molecule WEE1 inhibitor, recently entered the clinic.

About DATS DatChat Inc.

DatChat Inc is a blockchain, cybersecurity, and social media company that not only focuses on protecting privacy on personal devices, but also protects user information after it is shared with others. Its mobile messaging application is called DatChat Messenger which is a free messaging application. The platform allows users to exercise control over their messages and posts.

Share on Social Networks: